Literature DB >> 12834807

Signalling from adenosine receptors to mitogen-activated protein kinases.

Gunnar Schulte1, Bertil B Fredholm.   

Abstract

The purine nucleoside adenosine acts via four distinct adenosine receptor subtypes: the adenosine A(1), A(2A), A(2B), and A(3) receptor. They are all G protein-coupled receptors (GPCR) coupling to classical second messenger pathways such as modulation of cAMP production or the phospholipase C (PLC) pathway. In addition, they couple to mitogen-activated protein kinases (MAPK), which could give them a role in cell growth, survival, death and differentiation. Although each of the adenosine receptors can activate one or more of the MAPKs, the mechanisms appear to differ substantially, both between receptor subtypes in the same cell type and between the same receptor in different cell types.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12834807     DOI: 10.1016/s0898-6568(03)00058-5

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  143 in total

1.  Role of ω-hydroxylase in adenosine-mediated aortic response through MAP kinase using A2A-receptor knockout mice.

Authors:  Dovenia S Ponnoth; Mohammed A Nayeem; Swati S Kunduri; Stephen L Tilley; Darryl C Zeldin; Catherine Ledent; S Jamal Mustafa
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-12-07       Impact factor: 3.619

2.  Transgenic over expression of ectonucleotide triphosphate diphosphohydrolase-1 protects against murine myocardial ischemic injury.

Authors:  Ming Cai; Zachary M Huttinger; Heng He; Weizhi Zhang; Feng Li; Lauren A Goodman; Debra G Wheeler; Lawrence J Druhan; Jay L Zweier; Karen M Dwyer; Guanglong He; Anthony J F d'Apice; Simon C Robson; Peter J Cowan; Richard J Gumina
Journal:  J Mol Cell Cardiol       Date:  2011-09-12       Impact factor: 5.000

3.  SCH58261 the selective adenosine A(2A) receptor blocker modulates ischemia reperfusion injury following bilateral carotid occlusion: role of inflammatory mediators.

Authors:  R A Mohamed; A M Agha; N N Nassar
Journal:  Neurochem Res       Date:  2011-11-10       Impact factor: 3.996

4.  A(2b) adenosine receptors can change their spots.

Authors:  Michael V Cohen; Xiulan Yang; James M Downey
Journal:  Br J Pharmacol       Date:  2010-04       Impact factor: 8.739

Review 5.  Beneficial and detrimental role of adenosine signaling in diseases and therapy.

Authors:  Hong Liu; Yang Xia
Journal:  J Appl Physiol (1985)       Date:  2015-08-27

Review 6.  Molecular mechanisms of liver preconditioning.

Authors:  Elisa Alchera; Caterina Dal Ponte; Chiara Imarisio; Emanuele Albano; Rita Carini
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

7.  A2B adenosine receptor agonist induces cell cycle arrest and apoptosis in breast cancer stem cells via ERK1/2 phosphorylation.

Authors:  Seyyed Mehdi Jafari; Hamid Reza Joshaghani; Mojtaba Panjehpour; Mahmoud Aghaei
Journal:  Cell Oncol (Dordr)       Date:  2017-12-07       Impact factor: 6.730

Review 8.  Adenosine and bone metabolism.

Authors:  Aránzazu Mediero; Bruce N Cronstein
Journal:  Trends Endocrinol Metab       Date:  2013-03-14       Impact factor: 12.015

9.  Blocking A2B adenosine receptor alleviates pathogenesis of experimental autoimmune encephalomyelitis via inhibition of IL-6 production and Th17 differentiation.

Authors:  Wei Wei; Changsheng Du; Jie Lv; Guixian Zhao; Zhenxin Li; Zhiying Wu; György Haskó; Xin Xie
Journal:  J Immunol       Date:  2012-12-05       Impact factor: 5.422

10.  Adenosine A2A receptor-dependent proliferation of pulmonary endothelial cells is mediated through calcium mobilization, PI3-kinase and ERK1/2 pathways.

Authors:  Aftab Ahmad; Jerome B Schaack; Carl W White; Shama Ahmad
Journal:  Biochem Biophys Res Commun       Date:  2013-04-10       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.